This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Dec;14(13):1247-8.

doi: 10.1016/S1470-2045(13)70527-8. Epub 2013 Nov 13.

Biomarker for high-risk patients with stage II colon cancer

Toshiaki Watanabe¹

Affiliations

PMID: 24239206
DOI: 10.1016/S1470-2045(13)70527-8

Comment

Biomarker for high-risk patients with stage II colon cancer

Toshiaki Watanabe. Lancet Oncol. 2013 Dec.

. 2013 Dec;14(13):1247-8.

doi: 10.1016/S1470-2045(13)70527-8. Epub 2013 Nov 13.

Author

Toshiaki Watanabe¹

Affiliation

¹ Department of Surgical Oncology, the University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. Electronic address: toshwatanabe@yahoo.co.jp.

PMID: 24239206
DOI: 10.1016/S1470-2045(13)70527-8

No abstract available

PubMed Disclaimer

Comment on

Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX, Song W, Chen ZH, Wei JH, Liao YJ, Lei J, Hu M, Chen GZ, Liao B, Lu J, Zhao HW, Chen W, He YL, Wang HY, Xie D, Luo JH. Zhang JX, et al. Lancet Oncol. 2013 Dec;14(13):1295-306. doi: 10.1016/S1470-2045(13)70491-1. Epub 2013 Nov 13. Lancet Oncol. 2013. PMID: 24239208

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations